Basit öğe kaydını göster

dc.contributor.authorYÜCEYAR, AYŞE NUR
dc.contributor.authorGÜMÜŞ, HALUK
dc.contributor.authorArslan, Gokhan
dc.contributor.authorKilic, Ahmet Kasim
dc.contributor.authorAltintas, Ayse
dc.contributor.authorTURAN, ÖMER FARUK
dc.contributor.authorTutuncu, Melih
dc.contributor.authorTERZİ, MURAT
dc.contributor.authorAcar, Pinar
dc.contributor.authorBÜNÜL, SENA DESTAN
dc.contributor.authorBalci, Belgin Petek
dc.contributor.authorBİR, LEVENT SİNAN
dc.contributor.authorKoseoglu, Mesrure
dc.contributor.authorMungan, Semra
dc.contributor.authorGunduz, Tuncay
dc.contributor.authorDogan, Ipek Gungor
dc.contributor.authorKotan, Dilcan
dc.contributor.authorUygunoglu, Ugur
dc.contributor.authorEKMEKCİ, ÖZGÜL
dc.contributor.authorDEMİRKIRAN, DURUHAN MELTEM
dc.contributor.authorKAMIŞLI, ÖZDEN
dc.contributor.authorCANBAZ KABAY, SİBEL
dc.contributor.authorTamam, Yusuf
dc.contributor.authorOmerhoca, Sami
dc.contributor.authorSevim, Serhan
dc.contributor.authorGuler, Sibel
dc.contributor.authorKurtuncu, Murat
dc.contributor.authorEFENDİ, HÜSNÜ
dc.contributor.authorKARABUDAK, RANA
dc.contributor.authorSİVA, AKSEL
dc.contributor.authorSen, Sedat
dc.contributor.authorTuncer, Asli
dc.contributor.authorÖZAKBAŞ, SERKAN
dc.contributor.authorUzunkopru, Cihat
dc.contributor.authorBaba, Cavid
dc.contributor.authorDemir, Serkan
dc.contributor.authorBECKMANN, YEŞİM
dc.date.accessioned2022-07-04T13:18:23Z
dc.date.available2022-07-04T13:18:23Z
dc.identifier.citationSen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., BECKMANN Y., GÜMÜŞ H., Arslan G., Kilic A. K. , et al., "The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?", MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.58, 2022
dc.identifier.issn2211-0348
dc.identifier.othervv_1032021
dc.identifier.otherav_431ca4c6-149b-47e6-a04b-c9d4005a9c68
dc.identifier.urihttp://hdl.handle.net/20.500.12627/182502
dc.identifier.urihttps://doi.org/10.1016/j.msard.2021.103399
dc.description.abstractBackground: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectNeurology
dc.subjectNeurology (clinical)
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleThe Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
dc.typeMakale
dc.relation.journalMULTIPLE SCLEROSIS AND RELATED DISORDERS
dc.contributor.departmentOndokuz Mayıs Üniversitesi , ,
dc.identifier.volume58
dc.contributor.firstauthorID3423529


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster